Table 1.
Comparison of demographic and clinical characteristics between chemotherapy resistant and sensitive patients of 92 cases epithelial ovarian cancer
| Characteristics | N | Sensitive Group | Resistant Group | P-value |
|---|---|---|---|---|
|
| ||||
| n = 56 | n = 36 | |||
| Age, years | ||||
| Mean ± SD | 54.15 ± 9.48 | 52.70 ± 9.28 | 56.42 ± 9.48 | 0.066† |
| Age group, n (%) | ||||
| ≤ 60 | 74 | 47 (83.9) | 27 (75.0) | 0.292‡ |
| > 60 | 18 | 9 (16.1) | 9 (25.0) | |
| FIGO Stage, n (%) | ||||
| I-II | 31 | 27 (48.2) | 4 (11.1) | < 0.001*,‡ |
| III-IV | 61 | 29 (51.8) | 32 (88.9) | |
| Differentiation, n (%) | ||||
| Well | 14 | 10 (17.9) | 4 (11.1) | 0.318‡ |
| Moderate | 43 | 28 (50.0) | 15 (41.7) | |
| Poor | 35 | 18 (32.1) | 17 (47.2) | |
| Pathological Subtype, n (%) | ||||
| Serous carcinoma | 60 | 36 (64.3) | 24 (66.7) | 0.815‡ |
| Non-serous carcinoma | 32 | 20 (35.7) | 12 (33.3) | |
| Lymph node metastasis, n (%) | ||||
| No | 63 | 43 (76.8) | 20 (55.6) | 0.032*,‡ |
| Yes | 29 | 13 (23.2) | 16 (44.4) | |
| Residual tumor size, n (%) | ||||
| ≤ 1 cm | 53 | 41 (73.2) | 12 (33.3) | < 0.001*,‡ |
| > 1 cm | 39 | 15 (26.8) | 24 (66.7) | |
*
P < 0.05;
†
Independent t-test;
‡
Chi-square test.